APA (7th ed.) Citation

R, A., M, Z., EJ, C., & K, T. (2023). Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: The MAIN-MS study. Frontiers in neurology, 14, 1257455. https://doi.org/10.3389/fneur.2023.1257455

Chicago Style (17th ed.) Citation

R, Al-Roughani, Zakaria M, Cupler EJ, and Taha K. "Adherence to Subcutaneous Interferon Beta-1a Treatment Among Patients with Relapsing Multiple Sclerosis: The MAIN-MS Study." Frontiers in Neurology 14 (2023): 1257455. https://doi.org/10.3389/fneur.2023.1257455.

MLA (9th ed.) Citation

R, Al-Roughani, et al. "Adherence to Subcutaneous Interferon Beta-1a Treatment Among Patients with Relapsing Multiple Sclerosis: The MAIN-MS Study." Frontiers in Neurology, vol. 14, 2023, p. 1257455, https://doi.org/10.3389/fneur.2023.1257455.